C R Bard Inc - proposed acquisition of Edwards Lifesciences Corporation's worldwide peripheral vascular stent business
Type of assessment
Informal Review
Reference
30682
Acquirer(s)
C R Bard Inc
Target(s)
Edwards Lifesciences Corporation
Industry
Vascular Stent Business
Outcome of assessment
Not opposed
Total review days *
11
Commenced public review
19th December 2007
Date completed
8th January 2008
Market definition
The ACCC considered there to be separate Australian markets for the supply of ballon-expanding stents and for the supply of self-expanding stents.
Competition analysis
On 8 January 2008, the ACCC formed the view that the proposed acquisition was unlikely to substantially lessen competition in the relevant markets. Factors informing this conclusion included that the merged entity would continue to be constrained by the presence of alternative suppliers of balloon-expanding stents and self-expanding stents.
Review timeline
Date
Event
19th December 2007
ACCC commenced review under Merger Review Process Guidelines. Market inquiries commenced.
4th January 2008
Closing date for submissions from interested parties.
8th January 2008
ACCC announced it would not oppose the proposed acquisition.
* Total Review days = Total business days less public holidays and time during which the review was suspended.
